Financials data is unavailable for this security.
Cash flow in USDView more
In 2023, Immunome Inc increased its cash reserves by 383.67%, or 78.36m. Cash Flow from Financing totalled 116.41m or 830.42% of revenues. In addition the company used 7.57m for operations while cash used for investing totalled 30.48m.
Cash flow per share | -6.29 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 4.23 |
---|---|
Tangible book value per share | 4.23 |
More ▼
Balance sheet in USDView more
Current ratio | 7.12 |
---|---|
Quick ratio | -- |
Total debt/total equity | 0.00 |
---|---|
Total debt/total capital | 0.00 |
More ▼